Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

cp pharmaceuticals ltd. - tamoxifen (tamoxifen citrate) - tablets film-coated - 20mg

Armenia - engelsk - Դեղերի և բժշկական տեխնոլոգիաների փորձագիտական կենտրոնի գործունեության Հայաստանի Հանրապետությունում

cp pharmaceuticals ltd. - tamoxifen (tamoxifen citrate) - tablets film-coated - 10mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamoxifen citrate -

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

viatris gx bv-srl - tamoxifen citrate 30,4 mg - eq. tamoxifen 20 mg - tablet - 20 mg - tamoxifen citrate 30.4 mg - tamoxifen

Belgia - engelsk - AFMPS (Agence Fédérale des Médicaments et des Produits de Santé)

sandoz sa-nv - tamoxifen citrate 30,4 mg - eq. tamoxifen 20 mg - film-coated tablet - 20 mg - tamoxifen citrate 30.4 mg - tamoxifen

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

southern cross pharma pty ltd - tamoxifen citrate, quantity: 30.34 mg (equivalent: tamoxifen, qty 20 mg) - tablet - excipient ingredients: lactose monohydrate; povidone; maize starch; magnesium stearate; brilliant scarlet 4r - treatment of breast cancer genrx tamoxifen is indicated for the treatment of breast cancer.,primary reduction of breast cancer risk genrx tamoxifen is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Storbritannia - engelsk - MHRA (Medicines & Healthcare Products Regulatory Agency)

teva uk ltd - tamoxifen citrate - oral tablet - 10mg

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

aspen pharmacare australia pty ltd - tamoxifen citrate -

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - tamoxifen citrate, quantity: 15.2 mg (equivalent: tamoxifen, qty 10 mg) - tablet, film coated - excipient ingredients: hypromellose; povidone; lactose monohydrate; sodium starch glycollate; titanium dioxide; macrogol 4000; microcrystalline cellulose; magnesium stearate - treatment of breast cancer. ? tamoxifen sandoz is indicated for the treatment of breast cancer.,primary reduction of breast cancer risk ? tamoxifen sandoz is indicated for the primary reduction of breast cancer risk in women either at moderately increased risk (lifetime breast cancer risk 1.5 to 3 times the population average) or high risk (lifetime breast cancer risk greater than 3 times the population average).

Australia - engelsk - Department of Health (Therapeutic Goods Administration)

medis pharma pty ltd - tamoxifen citrate -